Therapeutics: Major histocompatibility complex class I A 2 (HLA-A2)

Cell culture and mouse studies suggest Tregs engineered to express a chimeric antigen receptor (CAR) against HLA-A2 could help treat GvHD. In co-culture with primary human peripheral blood mononuclear...